Emmanuelle Masson

Emmanuelle Masson

Auto-generated profile, based on publicly available information

Emmanuelle Masson

Univ Brest, Inserm, EFS, UMR 1078, GGB, F-29200, Brest, France; Service de Génétique Médicale et de Biologie de la Reproduction, CHRU Brest, F-29200, Brest, France

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
HWHeiko Witt
Heiko Witt
SBSebastian Beer
Sebastian Beer
JRJonas Rosendahl
Jonas Rosendahl
Jian-Min ChenJian-Min Chen
Jian-Min Chen
GCGiriraj Ratan Chandak
Giriraj Ratan Chandak
MSMiklos Sahin-Toth
Miklos Sahin-Toth

16 March 2015 in Nature Genetics
Verified
Journal Article
Open access
PDF file
KFKarianne Fjeld
Karianne Fjeld
FWFrank Ulrich Weiss
Frank Ulrich Weiss
DLDenise Lasher
Denise Lasher
JRJonas Rosendahl
Jonas Rosendahl
Jian-Min ChenJian-Min Chen
Jian-Min Chen
AMAnders Molven
Anders Molven
Anders Molven and colleagues show that a recombined allele of the lipase gene CEL and its pseudogene CELP confers susceptibility to chronic pancreatitis. The hybrid allele is associated with approximately fivefold-higher risk of disease, and it encodes a protein with reduced lipolytic activity and prominent intracellular accumulation. Carboxyl ester lipase is a digestive pancreatic enzyme encoded by the CEL gene1. Mutations in CEL cause maturity-onset diabetes of the young as well as pancreatic exocrine dysfunction2. Here we describe a hybrid allele (CEL-HYB) originating from a crossover between CEL and its neighboring pseudogene, CELP. In a discovery series of familial chronic pancreatitis cases, we observed CEL-HYB in 14.1% (10/71) of cases compared to 1.0% (5/478) of controls (odds ratio (OR) = 15.5; 95% confidence interval (CI) = 5.1–46.9; P = 1.3 × 10−6 by two-tailed Fisher's exact test). In three replication studies of nonalcoholic chronic pancreatitis, we identified CEL-HYB in a total of 3.7% (42/1,122) cases and 0.7% (30/4,152) controls (OR = 5.2; 95% CI = 3.2–8.5; P = 1.2 × 10−11; formal meta-analysis). The allele was also enriched in alcoholic chronic pancreatitis. Expression of CEL-HYB in cellular models showed reduced lipolytic activity, impaired secretion, prominent intracellular accumulation and induced autophagy. These findings implicate a new pathway distinct from the protease-antiprotease system of pancreatic acinar cells in chronic pancreatitis.

29 October 2006 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CMCédric Le Maréchal
Cédric Le Maréchal
EMEmmanuelle Masson
Emmanuelle Masson
Jian-Min ChenJian-Min Chen
Jian-Min Chen
FMFrédéric Morel
Frédéric Morel
PRPhilippe Ruszniewski
Philippe Ruszniewski
Claude FérecClaude Férec
Claude Férec

3 January 2008 in Human Genetics
Verified
Journal Article
Closed access
PDF file
EMEmmanuelle Masson
Emmanuelle Masson
Jian-Min ChenJian-Min Chen
Jian-Min Chen
VSVirginie Scotet
Virginie Scotet
CMCédric Le Maréchal
Cédric Le Maréchal
CFClaude Férec
Claude Férec

24 September 2014 in Gut
Verified
Journal Article
Closed access
PDF file
MDMonique H Derikx
Monique H Derikx
PKPeter Kovacs
Peter Kovacs
MSMarkus Scholz
Markus Scholz
EMEmmanuelle Masson
Emmanuelle Masson
Jian-Min ChenJian-Min Chen
Jian-Min Chen
JRJonas Rosendahl
Jonas Rosendahl
Objective: Several genetic risk factors have been identified for non-alcoholic chronic pancreatitis (NACP). A genome-wide association study reported an association of chronic pancreatitis (CP) with variants in PRSS1–PRSS2 (rs10273639; near the gene encoding cationic trypsinogen) and CLDN2–MORC4 loci (rs7057398 in RIPPLY1 and rs12688220 in MORC4). We aimed to refine these findings in a large European cohort. Design: We studied 3062 patients with alcohol-related CP (ACP) or NACP and 5107 controls. Also, 1559 German patients with alcohol-associated cirrhosis or alcohol dependence were included for comparison. We performed several meta-analyses to examine genotype–phenotype relationships. Results: Association with ACP was found for rs10273639 (OR, 0.63; 95% CI 0.55 to 0.72). ACP was also associated with variants rs7057398 and rs12688220 in men (OR, 2.26; 95% CI 1.94 to 2.63 and OR, 2.66; 95% CI 2.21 to 3.21, respectively) and in women (OR, 1.57; 95% CI 1.14 to 2.18 and OR 1.71; 95% CI 1.41 to 2.07, respectively). Similar results were obtained when German patients with ACP were compared with those with alcohol-associated cirrhosis or alcohol dependence. In the overall population of patients with NACP, association with rs10273639 was absent (OR, 0.93; 95% CI 0.79 to 1.01), whereas rs7057398 of the X chromosomal single nucleotide polymorphisms was associated with NACP in women only (OR, 1.32; 95% CI 1.15 to 1.51). Conclusions: The single-nucleotide polymorphisms rs10273639 at the PRSS1–PRSS2 locus and rs7057398 and rs12688220 at the CLDN2–MORC4 locus are associated with CP and strongly associate with ACP, but only rs7057398 with NACP in female patients.

28 July 2017 in Gut
Verified
Journal Article
Open access
PDF file
JRJonas Rosendahl
Jonas Rosendahl
HKHolger Kirsten
Holger Kirsten
EHEszter Hegyi
Eszter Hegyi
PKPeter Kovacs
Peter Kovacs
FWFrank Ulrich Weiss
Frank Ulrich Weiss
MSMiklos Sahin-Toth
Miklos Sahin-Toth
Objective: Alcohol-related pancreatitis is associated with a disproportionately large number of hospitalisations among GI disorders. Despite its clinical importance, genetic susceptibility to alcoholic chronic pancreatitis (CP) is poorly characterised. To identify risk genes for alcoholic CP and to evaluate their relevance in non-alcoholic CP, we performed a genome-wide association study and functional characterisation of a new pancreatitis locus. Design: 1959 European alcoholic CP patients and population-based controls from the KORA, LIFE and INCIPE studies (n=4708) as well as chronic alcoholics from the GESGA consortium (n=1332) were screened with Illumina technology. For replication, three European cohorts comprising 1650 patients with non-alcoholic CP and 6695 controls originating from the same countries were used. Results: We replicated previously reported risk loci CLDN2-MORC4 , CTRC , PRSS1-PRSS2 and SPINK1 in alcoholic CP patients. We identified CTRB1-CTRB2 (chymotrypsin B1 and B2) as a new risk locus with lead single-nucleotide polymorphism (SNP) rs8055167 (OR 1.35, 95% CI 1.23 to 1.6). We found that a 16.6 kb inversion in the CTRB1-CTRB2 locus was in linkage disequilibrium with the CP-associated SNPs and was best tagged by rs8048956 . The association was replicated in three independent European non-alcoholic CP cohorts of 1650 patients and 6695 controls (OR 1.62, 95% CI 1.42 to 1.86). The inversion changes the expression ratio of the CTRB1 and CTRB2 isoforms and thereby affects protective trypsinogen degradation and ultimately pancreatitis risk. Conclusion: An inversion in the CTRB1-CTRB2 locus modifies risk for alcoholic and non-alcoholic CP indicating that common pathomechanisms are involved in these inflammatory disorders.